Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Center for Immunication and Respiratory Diseases (NCIRD)
Type
Immunization Demonstration Projects Cooperative Agreements (U66)
Project #
1U66IP000519-01
Application #
8261784
Study Section
Special Emphasis Panel (ZIP1-SRC (99))
Project Start
2011-09-01
Project End
2014-08-31
Budget Start
2011-09-01
Budget End
2012-08-31
Support Year
1
Fiscal Year
2011
Total Cost
$319,100
Indirect Cost

  Institution

Name
Kid Risk, Inc.
Department
Type
DUNS #
026724883
City
Boston
State
MA
Country
United States
Zip Code
02210

  Publications

Kalkowska, Dominika A; Duintjer Tebbens, Radboud J; Grotto, Itamar et al. (2015) Modeling options to manage type 1 wild poliovirus imported into Israel in 2013. J Infect Dis 211:1800-12
Kalkowska, Dominika A; Duintjer Tebbens, Radboud J; Pallansch, Mark A et al. (2015) Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination. BMC Infect Dis 15:66
Duintjer Tebbens, Radboud J; Pallansch, Mark A; Wassilak, Steven G F et al. (2015) Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria. PLoS One 10:e0130123
Duintjer Tebbens, Radboud J; Pallansch, Mark A; Thompson, Kimberly M (2015) Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs. BMC Infect Dis 15:379
Duintjer Tebbens, Radboud J; Pallansch, Mark A; Cochi, Stephen L et al. (2015) An economic analysis of poliovirus risk management policy options for 2013-2052. BMC Infect Dis 15:389
Kisjes, Kasper H; Duintjer Tebbens, Radboud J; Wallace, Gregory S et al. (2014) Individual-based modeling of potential poliovirus transmission in connected religious communities in North America with low uptake of vaccination. J Infect Dis 210 Suppl 1:S424-33
Duintjer Tebbens, Radboud J; Pallansch, Mark A; Kim, Jong-Hoon et al. (2013) Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs). Risk Anal 33:680-702
Thompson, Kimberly M; Strebel, Peter M; Dabbagh, Alya et al. (2013) Enabling implementation of the Global Vaccine Action Plan: developing investment cases to achieve targets for measles and rubella prevention. Vaccine 31 Suppl 2:B149-56
Duintjer Tebbens, Radboud J; Pallansch, Mark A; Kalkowska, Dominika A et al. (2013) Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses. Risk Anal 33:703-49